FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to pharmacology and oncology. Disclosed is use of 4-phenyl-3,4-dihydro-2H-benzo[e][1,3]oxazine-2-thione of formula (I), presented below, in the treatment of malignant diseases.
EFFECT: use of the compound of formula (I) enables reducing acute toxicity, increasing the anti-tumour and antimetastatic effect in forming a syngeneic model of a tumour, as well as providing higher antineoplastic and antimetastatic activity in urothelial carcinoma.
1 cl, 3 dwg, 5 tbl, 4 ex
(I)
| Title | Year | Author | Number |
|---|---|---|---|
| 2-AMINIUM-7-(DIETHYLAMINO)-4-(4-METHOXIBENZO[D][1,3]DIOXOL-5-YL)-4H-CHROMEN-3-CARBONITRILE N-ACETYLAMINOETHANOAT HAVING ANTITUMOR ACTIVITY | 2018 |
|
RU2674987C1 |
| NEW 9-AMINOACRIDONE DERIVATIVE WITH ANTITUMOR AND ANTIMETASTATIC ACTIVITY | 2021 |
|
RU2810783C2 |
| 2-AMINOCHROMEN DERIVATIVES EXHIBITING ANTI-TUMOR ACTIVITY; PHARMACEUTICAL COMPOSITIONS | 2018 |
|
RU2704262C1 |
| AGENT FOR CORRECTING CYTOTOXIC EFFECTS OF PARANEOPLASTIC PROCESSES AND CHEMOTHERAPY SHOWING ANTICANCER ACTIVITY | 2011 |
|
RU2447888C1 |
| BACILLUS SUBTILIS-BASED LYOPHILISATE FOR ANTI-TUMOUR IMMUNITY REPROGRAMMING | 2023 |
|
RU2821073C1 |
| REMEDY WITH ANTI-TUMOR EFFECT FOR TREATMENT OF ONCOLOGICAL DISEASES | 2018 |
|
RU2761429C2 |
| MEANS OF SIMULTANEOUS PROTECTIVE ACTION IN RELATION TO HEALTHY ORGANS AND TISSUE AND ADJUVANT ACTION IN RADIO AND CHEMOTHERAPY OF TUMOURS | 2015 |
|
RU2646497C2 |
| AGENT WITH ANTITUMOUR AND ANTIMETASTATIC ACTIVITY, ANTI-INFLAMMATORY AND ANTIALLERGIC ACTION | 2018 |
|
RU2686672C1 |
| TETRAETHYL-2-(2,2,6,6-TETRAMETHYLPIPERIDIN-4-YLAMINO)-ETHYLENE-1,1-BISPHOSPHONATE POSSESSING ANTICANCER ACTIVITY | 2013 |
|
RU2506085C1 |
| ANTI-INFLAMMATORY MEDICATION WITH ANTICOAGULANT, ANTITUMOUR AND ANTIMETASTETIC ACTIVITY | 2009 |
|
RU2412712C1 |
